Bridge contract to extend service for Pharmaceutical Reverse Distribution

The contract with EXP Pharmaceutical Services, currently in its final option year, is set to expire on September 30, 2012. To ensure continuous service for the Department of Defense (DoD) and Department of Veterans Affairs (DVA) Pharmaceutical Prime Vendor programs, a bridge contract will be awarded beginning October 1, 2012, and running no later than September 30, 2013. This interim arrangement allows for the continued management of pharmaceutical returns and disposal of both hazardous and non-hazardous pharmaceutical waste until new competitive Reverse Distribution contracts are fully implemented. The coverage under this bridge contract will have staggered end dates: DoD coverage will end by September 30, 2013, while DVA coverage concludes earlier on February 28, 2013, due to a separate VA contracting initiative. The bridge contract facilitates the transition to the follow-on multiple award contracts, expected to be awarded on or before July 1, 2013. The contract is identified under solicitation number SPM200-07-D-5206 and falls within the NAICS code 493110, focusing on pharmaceutical reverse distribution services. Services will be performed primarily in Fremont, California. The contracting officer and specialist overseeing the contract are Vincent Valinotti and Alexander Quinones, respectively. This contract extension is critical to avoiding any service gaps for DoD and DVA customers during the competitive acquisition process for ongoing pharmaceutical reverse distribution support.